InsidersTradesSigma
基于 2 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
Discover the detailed record of transactions filed by Brandicourt Olivier. Insider active across 4 companies, notably BeiGene, Ltd.. In total, 9 filings have been logged. Activity tracked since 5 June 2024. The latest transaction was disclosed on 20 May 2026 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
9 条申报中的 9 条
BRANDICOURT OLIVIER is a declarant with 7 filings in total. The 7 sampled filings cover the period from 2024-06-07 to 2026-06-16, with buy volume of EUR 0 and sell volume of EUR 0. He is a director at BeOne Medicines Ltd., ALNYLAM PHARMACEUTICALS, INC., BeiGene, Ltd. and Vaxcyte, Inc., and the most common transaction nature is attribution.